Exclusive: U.S. cancer drugmaker Ignyta in advanced sale talks – sources

(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.

Source: Reuters Medical News

Leave a Reply

Your email address will not be published. Required fields are marked *